New IVF Reporting Guidelines Offer More Transparency To Help Fertility Patients Identify Best-In-Class Fertility Clinics

BASKING RIDGE, N.J., April 20, 2016 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey (RMANJ), known for their innovative and evidence-based infertility care, continues to lead the way with in vitro fertilization (IVF) success rates above the U.S. average. Annual data released recently by Society for Assisted Reproductive Technology (SART) for the year ending December 2014 shows RMANJ with success rates of 63.2% (n=886)* in women under age 35.

"Every potential patient who is exploring fertility care in New Jersey and across the US should look to SART first and review success rates by their age group," offered Dr. Michael R. Drews, a founding partner and medical director for RMANJ's main campus in Basking Ridge, NJ. "Patients should review the data with their healthcare provider. SART provides strong and federally mandated outcome data, offering hopeful patients powerful information that can help them improve their chance of being successful in the shortest time possible."

To provide better clarity and transparency for patients, SART has updated its reporting structure. Starting with the 2014 data, the SART report will break down success rates into embryo transfer attempt categories, including primary, secondary and all attempts. Live birth rates will now be reported per patient. The new 2014 fertility outcomes data report can be found at www.sart.org.

"For nearly 20 years, RMANJ has been focused on innovation and success. But success isn't just getting someone pregnant," said Dr. Thomas Molinaro, a partner at RMANJ and lead physician at the Eatontown, NJ office. "Our goal is a healthy pregnancy and delivery. And hopefully one baby at a time with single embryo transfer."

RMANJ offers the widest range of services including: IVF, SelectCCS (comprehensive chromosome screening), pre-implantation genetic diagnosis (PGD), fertility preservation services, egg donation, gestational surrogacy, acupuncture, yoga and patient-to-patient networking. "When starting your fertility journey, it's not just about finding any doctor or practice that can help you make your dreams come true. And it's not just about pregnancy rates. It's about delivery rates and how dedicated each doctor and nurse is to you and your needs," said RMANJ patient, Kim Genco, "Sites like SART.org, RESOLVE.org and FertiliTalk Patient Network are great tools for patients to access important information when choosing care," added Kim.

As required by the Fertility Clinic Success Rate and Certification Act of 1992, reproductive endocrinologists must report IVF delivery rates to the Centers for Disease Control and Prevention (CDC) and SART, the primary organization of professionals dedicated to the practice of assisted reproductive technologies in the United States.

RMANJ's full 2014 Clinic Summary Report can be viewed at www.sart.org.

ABOUT REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY

The experts at RMANJ offer IVF delivery rates of 63.2% percent in women under 35 (n=886) and well above the US average*. Since 1999, they have helped bring nearly 40,000 babies to loving families. RMANJ has 22 physicians and nine locations in New Jersey: Basking Ridge, Eatontown, Englewood, Freehold, Hamilton, Morristown, Short Hills, Somerset, West Orange, and a new 10^th location in Marlton, NJ opening in July 2016. For more information, please call 973-656-2089 or visit www.rmanj.com.

RMANJ pioneered and successfully implemented a cutting-edge technology known as Select Comprehensive Chromosome Screening (SelectCCS) to more accurately detect healthy embryos that has led to successful pregnancies and ultimately healthy babies. SelectCCS is owned and operated by the Foundation for Embryonic Competence (www.feclabs.org), and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.

*SART 2014; Cumulative Outcome Per Intended Retrieval; Preliminary Chance of Live Birth Per Cycle. Please note: A comparison of clinic success rates may not be meaningful because a patient's medical characteristics, treatment approaches and entrance criteria for assisted reproductive technology (ART) may vary from clinic to clinic. Visit www.sart.org to learn more.

ABOUT SART

Society for Assisted Reproductive Technology (SART) is the primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) in the United States. ART includes the practice of in vitro fertilization (IVF). The mission of our organization is to set up and help maintain the standards for ART in an effort to better serve our members and our patients. Visit www.sart.org to learn more.

Logo - http://photos.prnewswire.com/prnh/20151110/285995LOGO

SOURCE Reproductive Medicine Associates of New Jersey (RMANJ)

Related Links

http://www.rmanj.com